U.S. faces 'darkest winter' if pandemic planning falters: whistleblower
Send a link to a friend
[May 15, 2020]
By Jan Wolfe and Makini Brice
WASHINGTON (Reuters) - A whistleblower who
says he was removed from his government post for raising concerns about
coronavirus preparedness told a congressional hearing on Thursday that
the United States could face "the darkest winter" of recent times if it
does not improve its response to the pandemic.
Hours after President Donald Trump railed against him on Twitter,
whistleblower Rick Bright testified to a U.S. House of Representatives
panel about readiness for the outbreak.
Bright was removed last month as director of the Biomedical Advanced
Research and Development Authority, or BARDA, a part of the U.S.
Department of Health and Human Services responsible for developing drugs
to fight the coronavirus.
"What we do must be done carefully with guidance from the best
scientific minds. Our window of opportunity is closing. If we fail to
improve our response now, based on science, I fear the pandemic will get
worse and be prolonged," Bright said during his testimony.
The pandemic has infected nearly 1.4 million people in the United
States, gutted the economy and killed more than 82,000.
Bright testified to the subcommittee on health that he would "never
forget" an e-mail he got in January from a U.S. supplier of
medical-grade face masks warning of a dire shortage.
"He said 'we are in deep shit. The world is. We need to act,'" Bright
said. "And I pushed that forward to the highest level that I could of
HHS and got no response."
Bright testified that the U.S. still lacked a comprehensive plan for
ensuring a supply of basic supplies like swabs needed to administer
coronavirus tests.
Trump, who has been pushing for the U.S. economy to reopen quickly,
dismissed Bright as a "disgruntled employee" on Twitter on Thursday
morning before the hearing begun.
Later on Thursday, Trump told reporters at the White House that he had
watched some of Bright’s hearing.
"To me he's nothing more than a really disgruntled, unhappy person,"
Trump said, adding that he did not know Bright.
"Everything he's complaining about was achieved," HHS Secretary Alex
Azar told reporters.
Earlier this week, leading U.S. infectious disease expert Dr. Anthony
Fauci warned a Senate committee that a premature lifting of lockdowns
could lead to additional outbreaks of the deadly coronavirus. Trump on
Wednesday described Fauci's warning as not acceptable.
[to top of second column]
|
Dr. Richard Bright, former director of the Biomedical Advanced
Research and Development Authority, testifies during a House Energy
and Commerce Subcommittee on Health hearing to discuss protecting
scientific integrity in response to the coronavirus disease
(COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14,
2020. Shawn Thew/Pool via REUTERS
In a whistleblower complaint filed with a government watchdog last
week, Bright said that he warned about the virus in January and was
met with hostility from HHS leaders.
Bright, who was reassigned to a new government job last month, said
he was ousted from BARDA because he resisted efforts to push the
drugs hydroxychloroquine and the related chloroquine as cures for
COVID-19, the respiratory illness caused by the coronavirus.
Bright said in the statement last month that the U.S. government has
promoted the medicines as a "panacea" even though they "clearly lack
scientific merit."
HHS spokeswoman Caitlin Oakley has disputed Bright's account, saying
in a statement on Tuesday that he was transferred to a job where he
was entrusted to spend around $1 billion to develop diagnostic
testing.
"We are deeply disappointed that he has not shown up to work on
behalf of the American people and lead on this critical endeavor,"
Oakley said.
Bright testified that he has not started his new government job
because he has hypertension and took a medical leave.
The House subcommittee was also hearing on Thursday from Mike Bowen,
co-owner of Prestige Ameritech, the largest U.S. surgical mask
producer.
It was Bowen who sent Bright an email in January warning that the
United States would run out of medical-grade face masks if it did
not ramp up production, according to documents included in Bright's
whistleblower complaint.
(Reporting by Jan Wolfe and Makini Brice; Additional reporting by
Jeff Mason and Doina Chiacu; Editing by Scott Malone, Cynthia
Osterman and Alistair Bell)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |